Letermovir for CMV prophylaxis after haploidentical HSCT: a prospective study of direct and indirect effects. (PubMed, Int J Antimicrob Agents) - Mar 28, 2026 - P | "High-risk patients warrant enhanced immunological monitoring and extended letermovir prophylaxis."
Journal • Bone Marrow Transplantation • Cytomegalovirus Infection • Epstein-Barr Virus Infections • Infectious Disease • Transplantation • CD4 • CD8 • NCAM1
|
|
Chengsen Cai; Jia Chen; Shiyuan Zhou; Tong Cui; Xiaojin Wu; Yuejun Liu
|